| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5841641 | Life Sciences | 2015 | 35 Pages |
Abstract
These results support the idea that calcium supplementation via CaLa contributes to β-catenin degradation and is hypothesized to reduce the risk of CRC. In addition, it indicates the possibility of CaLa being a potential incorporating agent with existing therapeutics against CRC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yeong-Su Jang, Jae Jun Sim, Eunhee Ji, Keun-Yeong Jeong, Hwan Mook Kim,